Novo Nordisk A/S (NVO)
46.94
+0.20
(+0.44%)
USD |
NYSE |
Aug 24, 16:00
47.05
+0.10
(+0.22%)
After-Hours: 20:00
Novo Nordisk Price : 46.94 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 46.35 | 47.16 | 46.34 | 46.74 | 10.91M |
| Aug 20, 2026 | 46.89 | 46.90 | 46.11 | 46.14 | 9.670M |
| Aug 19, 2026 | 46.01 | 47.20 | 45.84 | 46.48 | 19.51M |
| Aug 18, 2026 | 44.91 | 46.06 | 44.76 | 45.71 | 12.09M |
| Aug 17, 2026 | 45.18 | 45.45 | 44.68 | 44.88 | 14.63M |
| Aug 14, 2026 | 46.90 | 47.04 | 45.75 | 45.89 | 10.85M |
| Aug 13, 2026 | 45.96 | 46.78 | 45.73 | 46.72 | 10.19M |
| Aug 12, 2026 | 45.87 | 46.55 | 45.56 | 46.39 | 9.564M |
| Aug 11, 2026 | 47.45 | 47.67 | 46.93 | 47.17 | 7.835M |
| Aug 10, 2026 | 47.00 | 47.74 | 46.66 | 47.73 | 10.19M |
| Aug 07, 2026 | 47.14 | 47.50 | 46.73 | 47.26 | 12.08M |
| Aug 06, 2026 | 45.61 | 45.98 | 44.93 | 45.97 | 13.12M |
| Aug 05, 2026 | 44.81 | 45.72 | 44.38 | 44.53 | 22.28M |
| Aug 04, 2026 | 47.58 | 49.15 | 43.68 | 44.28 | 47.48M |
| Aug 03, 2026 | 47.00 | 47.20 | 46.18 | 47.09 | 11.86M |
| Jul 31, 2026 | 47.40 | 47.59 | 46.44 | 47.08 | 26.80M |
| Jul 30, 2026 | 50.71 | 51.62 | 50.51 | 51.61 | 10.60M |
| Jul 29, 2026 | 51.00 | 52.12 | 50.92 | 51.58 | 8.713M |
| Jul 28, 2026 | 49.95 | 51.23 | 49.95 | 50.96 | 9.522M |
| Jul 27, 2026 | 49.18 | 49.96 | 48.82 | 49.67 | 6.806M |
| Jul 24, 2026 | 48.83 | 49.52 | 48.70 | 48.77 | 10.80M |
| Jul 23, 2026 | 48.38 | 48.93 | 48.11 | 48.18 | 8.178M |
| Jul 22, 2026 | 49.45 | 49.54 | 47.98 | 48.19 | 8.289M |
| Jul 21, 2026 | 49.34 | 49.84 | 48.95 | 49.38 | 5.786M |
| Jul 20, 2026 | 50.45 | 50.50 | 49.56 | 49.61 | 7.299M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 166.80 |
| Johnson & Johnson | 273.05 |
| Eli Lilly & Co. | 1247.64 |
| Merck & Co., Inc. | 150.72 |
| Novartis AG | 158.00 |
Price Related Metrics
| PE Ratio | 11.47 |
| PS Ratio | 4.056 |
| PEG Ratio | 0.9105 |
| Price to Book Value | 6.132 |
| Price to Free Cash Flow | 27.76 |
| Earnings Yield | 8.72% |
| Market Cap | 157.07B |
| PEGY Ratio | 0.6977 |
| Operating PE Ratio | 8.939 |
| Normalized PE Ratio | 11.03 |